Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

Related Articles by Review for PubMed (Select 21421841)

1.

Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration.

Jin M, Shepardson N, Yang T, Chen G, Walsh D, Selkoe DJ.

Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5819-24. doi: 10.1073/pnas.1017033108. Epub 2011 Mar 18.

2.

Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease.

Huang HC, Jiang ZF.

J Alzheimers Dis. 2009;16(1):15-27. doi: 10.3233/JAD-2009-0960. Review.

PMID:
19158417
3.

Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.

Bloom GS.

JAMA Neurol. 2014 Apr;71(4):505-8. doi: 10.1001/jamaneurol.2013.5847. Review.

PMID:
24493463
4.

Alzheimer's disease and amyloid: culprit or coincidence?

Skaper SD.

Int Rev Neurobiol. 2012;102:277-316. doi: 10.1016/B978-0-12-386986-9.00011-9. Review.

PMID:
22748834
5.

Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.

Ferrer I, Gomez-Isla T, Puig B, Freixes M, Ribé E, Dalfó E, Avila J.

Curr Alzheimer Res. 2005 Jan;2(1):3-18. Review.

PMID:
15977985
6.

Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.

Iqbal K, Alonso AC, Gong CX, Khatoon S, Pei JJ, Wang JZ, Grundke-Iqbal I.

J Neural Transm Suppl. 1998;53:169-80. Review.

PMID:
9700655
7.

Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach.

Iqbal K, Alonso AD, Gondal JA, Gong CX, Haque N, Khatoon S, Sengupta A, Wang JZ, Grundke-Iqbal I.

J Neural Transm Suppl. 2000;59:213-22. Review.

PMID:
10961432
8.

Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions.

Higuchi M, Iwata N, Saido TC.

Biochim Biophys Acta. 2005 Aug 1;1751(1):60-7. Epub 2005 Mar 17. Review.

PMID:
16054018
9.

Untangling amyloid-β, tau, and metals in Alzheimer's disease.

Savelieff MG, Lee S, Liu Y, Lim MH.

ACS Chem Biol. 2013 May 17;8(5):856-65. doi: 10.1021/cb400080f. Epub 2013 Mar 18. Review.

PMID:
23506614
10.

Alzheimer disease therapy--moving from amyloid-β to tau.

Giacobini E, Gold G.

Nat Rev Neurol. 2013 Dec;9(12):677-86. doi: 10.1038/nrneurol.2013.223. Epub 2013 Nov 12. Review.

PMID:
24217510
11.

Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior.

Selkoe DJ.

Behav Brain Res. 2008 Sep 1;192(1):106-13. doi: 10.1016/j.bbr.2008.02.016. Epub 2008 Feb 17. Review.

12.

Tau acts as a mediator for Alzheimer's disease-related synaptic deficits.

Liao D, Miller EC, Teravskis PJ.

Eur J Neurosci. 2014 Apr;39(7):1202-13. doi: 10.1111/ejn.12504. Review.

13.

Melatonin in Alzheimer's disease.

Lin L, Huang QX, Yang SS, Chu J, Wang JZ, Tian Q.

Int J Mol Sci. 2013 Jul 12;14(7):14575-93. doi: 10.3390/ijms140714575. Review.

14.

Alzheimer disease: a tale of two prions.

Nussbaum JM, Seward ME, Bloom GS.

Prion. 2013 Jan-Feb;7(1):14-9. doi: 10.4161/pri.22118. Epub 2012 Sep 10. Review.

15.

The intersection of amyloid β and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease.

Crimins JL, Pooler A, Polydoro M, Luebke JI, Spires-Jones TL.

Ageing Res Rev. 2013 Jun;12(3):757-63. doi: 10.1016/j.arr.2013.03.002. Epub 2013 Mar 22. Review.

16.

Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.

Jucker M, Walker LC.

Ann Neurol. 2011 Oct;70(4):532-40. doi: 10.1002/ana.22615. Review.

17.

New treatment strategies for Alzheimer's disease: is there a hope?

Aprahamian I, Stella F, Forlenza OV.

Indian J Med Res. 2013 Oct;138(4):449-60. Review.

18.

Senescence-accelerated OXYS rats: a model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease.

Stefanova NA, Kozhevnikova OS, Vitovtov AO, Maksimova KY, Logvinov SV, Rudnitskaya EA, Korbolina EE, Muraleva NA, Kolosova NG.

Cell Cycle. 2014;13(6):898-909. doi: 10.4161/cc.28255. Epub 2014 Feb 17. Review.

19.

The Beta-amyloid protein of Alzheimer's disease: communication breakdown by modifying the neuronal cytoskeleton.

Mokhtar SH, Bakhuraysah MM, Cram DS, Petratos S.

Int J Alzheimers Dis. 2013;2013:910502. doi: 10.1155/2013/910502. Epub 2013 Dec 12. Review.

20.

Alzheimer disease in 2020.

Holtzman DM, Mandelkow E, Selkoe DJ.

Cold Spring Harb Perspect Med. 2012 Nov 1;2(11). pii: a011585. doi: 10.1101/cshperspect.a011585. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk